Table 3—

Baseline characteristics of the subjects who progressed to diabetes and who remained nondiabetic at the 5-year follow-up examination

TraitIGT to diabetesPIGT to nondiabeticNGT to diabeticPNGT to IGTPNGT to NGT
Sex (F/M)14/220.08546/364/140.00153/570.0184*426/283
Age (years)66.2 ± 9.90.049*61.4 ± 9.160.8 ± 10.40.16562.4 ± 9.5<0.00156.0 ± 11.3
Height (cm)153.9 ± 7.80.788153.4 ± 7.6156.8 ± 6.00.991153.7 ± 8.20.039*156.0 ± 8.6
Body weight (kg)59.0 ± 9.60.71559.3 ± 9.959.0 ± 8.90.78557.2 ± 9.30.97557.4 ± 9.6
Waist circumference (cm)84.7 ± 7.70.25982.1 ± 8.481.3 ± 6.60.21879.7 ± 8.90.06977.6 ± 8.9
Hip circumference (cm)94.0 ± 5.50.62493.2 ± 5.891.3 ± 4.20.83792.1 ± 5.30.99692.1 ± 5.9
WHR0.901 ± 0.0610.2280.880 ± 0.0640.891 ± 0.0680.015*0.865 ± 0.0720.0070.841 ± 0.071
BMI (kg/m2)24.8 ± 2.80.50725.2 ± 3.423.9 ± 2.50.88624.2 ± 3.20.15523.6 ± 3.1
Percent body fat27.4 ± 6.60.31928.4 ± 8.223.4 ± 7.10.18926.7 ± 6.50.63126.3 ± 6.7
Fasting plasma glucose (mg/dl)105.3 ± 9.2<0.001*98.4 ± 9.0102.2 ± 13.9<0.00196.4 ± 9.4<0.00191.0 ± 8.0
2-h plasma glucose (mg/dl)164.0 ± 17.1<0.001*154.3 ± 12.4114.9 ± 19.50.002111.1 ± 19.9<0.00198.2 ± 20.6
HbA1c (%)5.95 ± 0.50<0.001*5.61 ± 0.375.63 ± 0.500.0035.50 ± 0.36<0.0015.30 ± 0.34
Fasting serum insulin (μU/ml)4.70 ± 2.580.1695.75 ± 3.924.30 ± 4.030.9954.51 ± 2.520.6054.29 ± 2.96
HOMA-IR1.23 ± 0.690.3681.41 ± 0.931.09 ± 1.080.8111.08 ± 0.620.3270.98 ± 0.73
Systolic blood pressure (mmHg)136.7 ± 17.20.563133.3 ± 16.8129.0 ± 20.50.377128.3 ± 14.60.019*123.5 ± 16.6
Diastolic blood pressure (mmHg)76.6 ± 9.80.30777.9 ± 9.774.2 ± 13.10.92175.7 ± 10.20.09973.3 ± 9.6
Total cholesterol (mg/dl)217.5 ± 33.80.943216.4 ± 35.4205.2 ± 37.90.980213.4 ± 37.00.072203.4 ± 36.7
Triglyceride (mg/dl)120.0 ± 80.80.886120.8 ± 53.8136.6 ± 117.60.317114.1 ± 57.40.637106.6 ± 74.3
HDL cholesterol (mg/dl)56.0 ± 15.30.93355.1 ± 14.258.8 ± 16.30.83556.4 ± 15.40.44958.0 ± 13.9
Adiponectin (10 × log μg/ml)8.27 ± 2.190.9128.32 ± 2.357.29 ± 2.350.0098.98 ± 2.320.6729.13 ± 2.35
TNF-α (10 × log pg/ml)11.6 ± 1.40.44811.8 ± 1.411.6 ± 1.20.71811.5 ± 1.50.28311.3 ± 1.3
  • Data are means ± SD. P values compared the IGT to diabetes group with the IGT to nondiabetic group, and the NGT to diabetes or the NGT to IGT groups with the NGT to NGT group.

  • *

    * P < 0.05;

  • P < 0.01.